Skip to Main content Skip to Navigation
Journal articles

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)

Abstract : .
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01407384
Contributor : Elizabeth Bernardo <>
Submitted on : Friday, December 2, 2016 - 9:09:04 AM
Last modification on : Monday, August 31, 2020 - 9:52:06 AM
Long-term archiving on: : Thursday, March 23, 2017 - 12:01:26 AM

File

AnnOncol2016Eq2.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

P. Saiag, R. Gutzmer, P. A. Ascierto, M. Maio, J.-J. Grob, et al.. Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). Annals of Oncology, Elsevier, 2016, 27, pp.1947 - 1953. ⟨10.1093/annonc/mdw291⟩. ⟨inserm-01407384⟩

Share

Metrics

Record views

205

Files downloads

391